H&J CRO International, Inc

News

Your current location：Home > News > COMPANY NEWS

Innovative motivation, mutual motion| H&J and Fosun Health Innovative Drug Funding reached strategic cooperation to2023-08-23
SIBP04-02 data review meeting held successfully2021-11-17
H&J: Awarded 50 best Chinese CRO company2021-11-17
Five years of collaboration, thank you!! (2019-10-14)2019-10-14
Thank you for working overtime today!(2019-10-13)2019-10-13
A Summary Table of Timelines for SUSAR Reports by H&J PV department(2019-10-13)2019-10-13
Bevacizumab Phase I Trial Started！(2019-10-12)2019-10-12
Taking Care of the CCC Database: 150000 ACS Completed at the Fifth Year Ceremony(2019-10-12)2019-10-12
Keep a Strong Mind—Dr. Philip’s Address After winning the Bidding of 35.5Million USD Oncology Project(2019-10-12)2019-10-12
Hua Medicine Drug Safety and Pharmacovigilance Experts came to H&J to explain the relevant knowledge of PV2019-04-17
Beijing：Winter gave place to spring2019-03-20
A Commendation Letter from a pharmaceutical company in Shanghai2019-03-19
H&J will hold Q1 quarterly management Cycle Meeting in 20192019-02-27
What kind of CRC do sponsors like?2019-02-25

Han Bo Rui Qiang (Shanghai) Pharma-Tech Ltd,?H&J CRO International--New York LLC? ?Copyright H&J 2019